ATE335496T1 - Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung - Google Patents

Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung

Info

Publication number
ATE335496T1
ATE335496T1 AT00918281T AT00918281T ATE335496T1 AT E335496 T1 ATE335496 T1 AT E335496T1 AT 00918281 T AT00918281 T AT 00918281T AT 00918281 T AT00918281 T AT 00918281T AT E335496 T1 ATE335496 T1 AT E335496T1
Authority
AT
Austria
Prior art keywords
analogues
adhesion formation
angiotensin
aii
limiting
Prior art date
Application number
AT00918281T
Other languages
English (en)
Inventor
Kathleen Rodgers
Gere Dizerega
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE335496T1 publication Critical patent/ATE335496T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT00918281T 1999-03-23 2000-03-22 Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung ATE335496T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12570799P 1999-03-23 1999-03-23
US13954199P 1999-06-16 1999-06-16

Publications (1)

Publication Number Publication Date
ATE335496T1 true ATE335496T1 (de) 2006-09-15

Family

ID=26823846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918281T ATE335496T1 (de) 1999-03-23 2000-03-22 Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung

Country Status (8)

Country Link
EP (1) EP1165099B1 (de)
JP (1) JP3745624B2 (de)
AT (1) ATE335496T1 (de)
AU (1) AU756156B2 (de)
CA (1) CA2367107C (de)
DE (1) DE60029937T2 (de)
ES (1) ES2267513T3 (de)
WO (1) WO2000056345A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747008B1 (en) 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
EP2377532A1 (de) 2004-08-18 2011-10-19 Ace ApS Kosmetische und pharmazeutische Zusammensetzungen mit ACE-Hemmern und/oder Angiotensin-II-Rezeptorantagonisten zur Behandlung von Hauterkrankungen
WO2006032143A1 (en) * 2004-09-23 2006-03-30 Arc Pharmaceuticals, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
CN102905719B (zh) * 2010-03-26 2015-04-22 南加利福尼亚大学 治疗复合性辐射和热损伤的方法
EP2455388A1 (de) 2010-11-23 2012-05-23 LanthioPep B.V. Neuartige Rezeptoragonisten von Angiotensin des Typs 2 (AT2) und Verwendungen dafür
US8557958B1 (en) 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
CN111163793A (zh) * 2017-07-17 2020-05-15 莫纳什大学 血管紧张素受体激动剂及其用途
WO2021023698A1 (en) 2019-08-02 2021-02-11 Lanthiopep B.V Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435301D1 (de) * 1993-09-24 2010-08-26 Univ Southern California Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
AU6650098A (en) * 1997-02-04 1998-08-25 University Of Southern California Method for accelerating healing of thermal injuries

Also Published As

Publication number Publication date
CA2367107A1 (en) 2000-09-28
JP3745624B2 (ja) 2006-02-15
WO2000056345A2 (en) 2000-09-28
WO2000056345A9 (en) 2002-06-27
EP1165099B1 (de) 2006-08-09
CA2367107C (en) 2003-10-14
EP1165099A2 (de) 2002-01-02
DE60029937T2 (de) 2007-09-06
WO2000056345A3 (en) 2001-01-11
DE60029937D1 (de) 2006-09-21
JP2002539267A (ja) 2002-11-19
ES2267513T3 (es) 2007-03-16
AU3911700A (en) 2000-10-09
AU756156B2 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
WO2000053211A3 (en) Method of promoting myocyte proliferation and myocardial tissue repair
BR0112292A (pt) Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
ID26984A (id) Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
MY138289A (en) Pharmaceutical compositions
BR0013200A (pt) Compostos derivados de heterobiciclos contendo nitrogênio, composições farmacêuticas, método de tratamento ou prevenção de uma disfunção tromboembólica e uso dos compostos
WO2000071507A3 (en) INHIBITORS OF FACTOR Xa
ES2619332T3 (es) Fosfatasa alcalina dirigida al hueso, kits y métodos de uso de la misma
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
ATE314062T1 (de) Zusammensetzungen zur abgabe von cortisolantagonisten
ATE410996T1 (de) Methoden zur behandlung von nägeln
SE0202598D0 (sv) Alpha-7 Nicotinic receptor agonists and statins in combination
DE60029937D1 (de) Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung
DE69924715D1 (de) Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung
EP1741713A3 (de) Biphenyl Sulfonamide als zweierlei Angiotensin Endothelin Rezeptor Antagonisten
BRPI0412919A (pt) combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
YU13301A (sh) Muskarinski agonisti i antagonisti
AU1023497A (en) Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
CA2323237A1 (en) Improved radiation therapy methods
EA200601592A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
WO2001055176A3 (en) Methods for inhibiting smooth muscle cell proliferation
WO2002006308A3 (en) Methods for promoting dendritic cell proliferation or differentiation
WO2001044270A3 (en) Methods for treating and preventing diabetic complications by use of angiotensin-related peptides
AU2003251729A1 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
CA2304712A1 (en) Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties